Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Harvard Business School
Merck
Baxter
Dow

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Actavis Mid Atlantic Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ACTAVIS MID ATLANTIC, and what generic and branded alternatives to ACTAVIS MID ATLANTIC drugs are available?

ACTAVIS MID ATLANTIC has sixty-two approved drugs.



Summary for Actavis Mid Atlantic

Drugs and US Patents for Actavis Mid Atlantic

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic ACETAMINOPHEN AND CODEINE PHOSPHATE acetaminophen; codeine phosphate SOLUTION;ORAL 085861-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Actavis Mid Atlantic BETAMETHASONE DIPROPIONATE betamethasone dipropionate OINTMENT;TOPICAL 071012-001 Feb 3, 1987 AB RX No No   Start Trial   Start Trial
Actavis Mid Atlantic DESOXIMETASONE desoximetasone OINTMENT;TOPICAL 204965-001 Nov 7, 2016 AB RX No No   Start Trial   Start Trial
Actavis Mid Atlantic HYDROCORTISONE hydrocortisone CREAM;TOPICAL 087795-001 May 3, 1983 AT RX No No   Start Trial   Start Trial
Actavis Mid Atlantic M-ZOLE 7 DUAL PACK miconazole nitrate CREAM, SUPPOSITORY;TOPICAL, VAGINAL 074586-001 Jul 17, 1997 DISCN No No   Start Trial   Start Trial
Actavis Mid Atlantic AMINOPHYLLINE DYE FREE aminophylline SOLUTION;ORAL 087727-001 Apr 16, 1982 DISCN No No   Start Trial   Start Trial
Actavis Mid Atlantic CETIRIZINE HYDROCHLORIDE cetirizine hydrochloride SYRUP;ORAL 078617-001 Feb 2, 2010 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
McKesson
McKinsey
Mallinckrodt
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.